TriNetX Launches Diversity Lens Analytic to Improve Access to Clinical Trials for Underrepresented Patient Populations

CAMBRIDGE, Mass. , Dec. 9, 2021 /PRNewswire/ — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced the launch of Diversity Lens, an analytic feature on the TriNetX platform which helps life sciences companies and healthcare organizations to leverage real-world data to understand and address race and ethnicity in clinical trial patient participation.

Read the source article at PR Newswire
2021-12-09 16:00:00